Allogeneic bone marrow transplantation in a child with hemoglobinopathy olmsted.
The authors describe the first successful bone marrow transplant for the treatment of hemoglobinopathy Olmsted in a boy who presented with severe transfusion-dependent hemolytic anemia and jaundice at age 4 months. He received bone marrow from an HLA-identical sibling with normal hemoglobin electrophoresis after conditioning with busulfan, cyclophosphamide, and antithymocyte globulin when he was 18 months old. The posttransplant course was uneventful. Two years after transplantation the patient has a normal hemoglobin level without evidence of hemolysis. DNA analysis shows 100% chimerism of donor cell origin, confirming full engraftment with normal hematopoietic cells.
Urban
Christian
C
Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Graz School of Medicine, Austria. christian.urban@kfunigraz.ac.at
Preisegger
Karl-Heinz
KH
Krugluger
Walter
W
Hopmeier
Pierre
P
Schwinger
Wolfgang
W
Lackner
Herwig
H
Kerbl
Reinhold
R
Dornbusch
Hans-Jürgen
HJ
Benesch
Martin
M
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D017931:DNA Primers / Q000737:chemistry; D005914:Globins / Q000235:genetics; D006453:Hemoglobinopathies / Q000235:genetics / Q000628:therapy*; D006455:Hemoglobins, Abnormal / Q000235:genetics*; D006801:Humans; D007223:Infant; D008297:Male; D009154:Mutation; D016133:Polymerase Chain Reaction; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous
D018906:Antineoplastic Agents, Alkylating; D017931:DNA Primers; D006455:Hemoglobins, Abnormal; C098095:hemoglobin Olmsted; D003520:Cyclophosphamide; D005914:Globins; D002066:Busulfan